Mutational analysis of Chk1, Chk2, Apaf1 and Rb1 in human malignant melanoma cell lines

Thilo Papp1, Annett Niemetz, Nils Dosdahl

  • 1Department of Biological Sciences, Institute of Cell Biology and Biosystems Technology, University of Rostock, Albert Einstein Strasse 3, 18051 Rostock, Germany. thilo.papp@biologie.uni-rostock.de

Oncology Reports
|December 5, 2006
PubMed

Insights

This study investigated tumor suppressor genes in melanoma cell lines, finding alterations in two lines. This suggests alternative p53 pathway disruptions contribute to melanoma development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Malignant melanoma is a therapy-resistant cancer.
  • The p53 pathway is crucial in cancer suppression.
  • Dysfunctional p53 pathway genes may contribute to melanoma.

Purpose of the Study:

  • To screen for alterations in four key tumor suppressor genes (Chk1, Chk2, Apaf1, Rb1) in human melanoma cell lines.
  • To investigate the role of p53 inducer/effector genes in melanoma etiology.
  • To explore alternative p53-pathway disruption mechanisms in melanoma.

Main Methods:

  • cDNA-based Differential Gel Electrophoresis (DGGE) and Single-Strand Conformation Polymorphism (SCCP) analysis.
  • Screening of Chk1, Chk2, Apaf1, and Rb1 genes for loss of expression, point mutations, and small deletions/insertions.
  • Analysis of nine human malignant melanoma cell lines.

Main Results:

  • Alterations in the investigated tumor suppressor genes were identified in two out of nine melanoma cell lines.
  • The findings support the involvement of dysfunctional p53 inducer/effector genes in human melanoma.
  • This study provides evidence for alternative mechanisms disrupting the p53 pathway in melanoma, independent of p53 mutations.

Conclusions:

  • Dysfunctional p53 pathway genes play a role in human melanoma etiology.
  • Alternative mechanisms disrupting the p53 pathway are likely important in melanoma.
  • This is the first study to screen for CHK1/CHK2 mutations in human melanoma.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...